Expansive remodeling in venous bypass grafts: Novel implications for vein graft disease

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 580-589

  Wong, Amy P ^a   Nili, Nafiseh ^a   Jackson, Zane S ^a   Qiang, Beiping ^a   Leong Poi, Howard ^a   Jaffe, Ronen ^a   Raanani, Ehud ^a   Connelly, Philip W ^a   Sparkes, John D ^a   Strauss, Bradley H ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Collagen; Matrix metalloproteinases; Remodeling; Vein graft disease

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE ELASTASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BYPASS SURGERY; CELL INFILTRATION; CHOLESTEROL DIET; COLLAGEN SYNTHESIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; HISTOLOGY; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR ULTRASOUND; JUGULAR VEIN; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; VEIN GRAFT DISEASE;

ANIMALS; BLOOD VESSEL PROSTHESIS; CAROTID ARTERY, COMMON; CHOLESTEROL, DIETARY; COLLAGEN; CORONARY ARTERY BYPASS; GRAFT OCCLUSION, VASCULAR; JUGULAR VEINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RABBITS; REGENERATION; TUNICA INTIMA;

EID: 38349147337     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.06.029     Document Type: Article

References (29)

1. Heart Centre Online, 2003. Available at http://www.heartcenteronline.com [accessed November 2].
2. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). Circulation 100 (1999) 1464-1480
3. Berger P.B., Velianou J.L., Aslanidou Vlachos H., et al. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 38 (2001) 1440-1449
4. Christenson J.T. Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. Am J Cardiol 88 (2001) 896-899 A898
5. Nishibe T., Muto A., Kaneko K., et al. True aneurysms in a saphenous vein graft placed for repair of a popliteal aneurysm: etiologic considerations. Ann Vasc Surg 18 (2004) 747-749
6. Sharifi M., Dillon J.C., and Pompili V.J. Saphenous vein graft ectasia: an unusual late complication of coronary artery bypass surgery. A case report. Angiology 50 (1999) 497-501
7. Cox J.L., Chiasson D.A., and Gotlieb A.I. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. Prog Cardiovasc Dis 34 (1991) 45-68
8. Schoenhagen P., Ziada K.M., Kapadia S.R., Crowe T.D., Nissen S.E., and Tuzcu E.M. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 101 (2000) 598-603
9. Smits P.C., Pasterkamp G., Quarles van Ufford M.A., et al. Coronary artery disease: arterial remodelling and clinical presentation. Heart 82 (1999) 461-464
10. Ehsan A., Mann M.J., Dell'Acqua G., and Dzau V.J. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thorac Cardiovasc Surg 121 (2001) 714-722
11. Li C., Cantor W.J., Nili N., et al. Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor. J Am Coll Cardiol 39 (2002) 1852-1858
12. Bendeck M.P., and Nakada M.T. The beta3 integrin antagonist m7E3 reduces matrix metalloproteinase activity and smooth muscle cell migration. J Vasc Res 38 (2001) 590-599
13. Larsen P.H., and Yong V.W. The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. J Neurosci 24 (2004) 7597-7603
14. Nili N., Zhang M., Strauss B.H., and Bendeck M.P. Biochemical analysis of collagen and elastin synthesis in the balloon injured rat carotid artery. Cardiovasc Pathol 11 (2002) 272-276
15. Southgate K.M., Mehta D., Izzat M.B., Newby A.C., and Angelini G.D. Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts. Arterioscler Thromb Vasc Biol 19 (1999) 1640-1649
16. George S.J., Lloyd C.T., Angelini G.D., Newby A.C., and Baker A.H. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 101 (2000) 296-304
17. Porter K.E., Naik J., Turner N.A., Dickinson T., Thompson M.M., and London N.J. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg 36 (2002) 150-157
18. Wentzel J.J., Kloet J., Andhyiswara I., et al. Shear-stress and wall-stress regulation of vascular remodeling after balloon angioplasty: effect of matrix metalloproteinase inhibition. Circulation 104 (2001) 91-96
19. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. The Post Coronary Artery Bypass Graft Trial Investigators. N Engl J Med 1997;336:153-62.
20. Shi Y., Patel S., Davenpeck K.L., et al. Oxidative stress and lipid retention in vascular grafts: comparison between venous and arterial conduits. Circulation 103 (2001) 2408-2413
21. Uzui H., Harpf A., Liu M., et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106 (2002) 3024-3030
22. Curci J.A., Liao S., Huffman M.D., Shapiro S.D., and Thompson R.W. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 102 (1998) 1900-1910
23. Shapiro S.D. Diverse roles of macrophage matrix metalloproteinases in tissue destruction and tumor growth. Thromb Haemost 82 (1999) 846-849
24. Hong M.K., Mintz G.S., Hong M.K., et al. Intravascular ultrasound assessment of the presence of vascular remodeling in diseased human saphenous vein bypass grafts. Am J Cardiol 84 (1999) 992-998
25. O'Blenes S.B., Zaidi S.H., Cheah A.Y., McIntyre B., Kaneda Y., and Rabinovitch M. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration. Circulation 102 (2000) III289-III295
26. Pasterkamp G., Schoneveld A.H., van der Wal A.C., et al. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 32 (1998) 655-662
27. Varnava A.M., Mills P.G., and Davies M.J. Relationship between coronary artery remodeling and plaque vulnerability. Circulation 105 (2002) 939-943
28. Hozumi T., Yoshikawa J., Yoshida K., et al. Use of intravascular ultrasound for in vivo assessment of changes in intimal thickness of angiographically normal saphenous vein grafts one year after aortocoronary bypass surgery. Heart 76 (1996) 317-320
29. Higuchi Y., Hirayama A., Shimizu M., Sakakibara T., and Kodama K. Postoperative changes in angiographically normal saphenous vein coronary bypass grafts using intravascular ultrasound. Heart Vessels 17 (2002) 57-60